Investor Ideas #Potcasts
592, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO), (TSX: $WEED.TO)
(NASDAQ: $CGC), (CSE: $DELC.C) (OTCQB: $DELCF) and (OTC: $KONEF)
Delta, Kelowna, BC, August 4, 2021 (Investorideas.com Newswire) www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/080421-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/08041FAF-WEED-CGC-DELC-KONEF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Fire
& Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF) and its wholly-owned subsidiary
Hifyre™ Inc., today announced the acquisition of certain
assets from subsidiaries of Wikileaf
Technologies Inc. (CSE: WIKI), an online platform for cannabis
enthusiasts and consumers, as part of its innovative new digital strategy
focused on enhancing the Company's proprietary data-driven retail platform.
Wikileaf, which generates
significant user traffic through engaging content and domain name strength,
will be boosted through the incorporation of Hifyre's unique data-driven
technology solutions into its existing platform. Hifyre will transform the
Wikileaf website into a virtual online dispensary for cannabis and accessory
products utilizing the same e-commerce proprietary technology platform that
powers the Fire & Flower retail network. Accessory products will be
fulfilled through Fire & Flower's agreement with Humble & Fume (CSE:
HBML) announced last month.
A key aspect of the new digital
strategy, Hifyre will create white-labelled online dispensaries fulfilled
initially by the Fire & Flower retail network, that can be expanded to
other cannabis dispensaries and delivery channels both in Canada and the U.S.
In addition, users of all white-labelled websites will be enrolled into Fire
& Flower's proprietary Spark Perks membership loyalty program, expanding
upon its ability to capture a high level of engagement and understanding of
cannabis consumer preferences and habits both in Canada and the U.S.
"Hifyre's expanded digital
strategy offers a significant opportunity to expand the Company's e-commerce
revenue channels through an asset-light and highly scalable model both in
Canada and the U.S.," shared Trevor Fencott, Chief Executive Officer of
Fire & Flower. "The branded online dispensary model is accretive to
our retail channel as it offers the opportunity to capture new customers and
drive an additional stream of high margin revenue through our Hifyre
platform."
"We believe owning the customer
relationship is the most prized part of the value chain and this has been
successfully achieved through membership in our Spark Perks program,"
shared Matthew Hollingshead, Chief Innovation Officer of Fire & Flower and
President of Hifyre. "Our ability to white-label our e-commerce platform
offers the opportunity for any brand to create a virtual online cannabis dispensary
through our proprietary technology."
In a recent article
from MJBIZDaily, Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) executives received more than 4 million CAD ($3.2 million
USD) in cash bonuses after making “solid progress in the year,” according to a
regulatory filing, even as the
company lost CA$1.7 billion and laid off hundreds of workers.
The Smiths Falls,
Ontario-based company disclosed the executive compensation figures for fiscal
year 2021 in a proxy statement sent ahead of its annual general meeting,
scheduled for Sept. 14 via webcast.
The executives’
compensation packages consist of salary as well as bonuses awarded as part of
the company’s short- and long-term incentive plans.
For fiscal 2021,
which ended March 31, the board approved short-term incentive plan bonuses
totaling CA$4 million for five of the company’s top executives.
The company’s
long-term incentive-plan (LTI) bonuses, typically granted annually in March,
were awarded June 9, 2021.
The LTI bonuses
were not reported in the total compensation table because they were issued
after the fiscal year ended.
“On a go forward
basis, we have determined to fix the regular timing of our annual LTI grants to
occur in June of each year, beginning in Fiscal 2022,” the proxy noted.
“As such, no LTI
awards were granted in Fiscal 2021, with the prior LTI grants having been made
in late March 2020 at the end of Fiscal 2020.”
In an emailed
statement, a company spokesperson told MJBizDaily
that “Canopy Growth’s executive compensation supports our strategy of
attracting and retaining top talent that is necessary to support the company’s
ambitious growth plans and is structured to ensure close alignment between the
interest of shareholders and leadership.”
The company uses
four performance measures related to corporate objectives to help guide
short-term bonus payouts where executives earn an annual cash bonus.
Free cash flow has
the heaviest weighting (50%) among the performance measures, followed by net
revenue (20%), adjusted EBITDA (20%) and individualized objectives (10%).
The company failed
to meet its fiscal 2021 goals for net revenue and adjusted EBITDA, but the
goals for free cash flow and individualized objectives were achieved.
According to the
proxy, Canopy aimed for net revenue of $455 million but came in at $414
million.
Free cash flow was
negative $478 million, or half the shortfall the company anticipated.
Adjusted EBITDA,
which serves as a measure of profitability, came in at negative $258 million, a
slightly worse performance compared with the company’s objective of negative
$246 million.
Canopy’s short-term
cash bonuses amounted to:
● CA$2.2
million for David Klein, CEO.
● CA$579,000
for Mike Lee, chief financial officer.
● CA$659,000
for Rade Kovacevic, president and chief product officer.
● CA$360,000
for Julious Grant, chief commercial officer.
● CA$351,000
for Phil Shaer, chief legal officer.
According
to the proxy statement, Canopy’s compensation committee “affirmed that the
executive leadership team performed well in progressing the company’s revised
CPG strategy and reorientation towards a path of reduced financial losses and
sustained success, all while acknowledging the challenging environment created
by the COVID-19 pandemic.”
The
executives also received grants on June 9 as part of their annual LTIP.
Those
ranged from 22,352 options and 11,176 share-based awards for Shaer to 139,488
options and 69,744 share-based awards for Klein.
The
share-based awards were granted in the form of performance share units (PSUs).
“The
number of PSUs granted represents 100% of the target number of PSUs. The
minimum PSU award is equal to 50% of the target number of PSUs, and the maximum
PSU award is 150% of the target number of PSUs,” the filing noted.
Going
forward, the filing adds, half of the executives’ long-term incentive grants
will consist of restricted share units and performance share units, and in
fiscal 2021, “no performance conditions were imposed on share unit awards
granted in March 2020 due to the difficulty in establishing reasonable
performance metrics due to the impacts of the COVID-19 outbreak.”
Big
thanks to Matt Lamers of MJBiz Daily for producing such
a great article.
Delic
Holdings Inc. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic
wellness platform, today announced that Itefayo Harvey will serve as one of the event's mainstage speakers.
Meet Delic is the world's premiere psychedelic and wellness edutainment event
catering to both curious newcomers, businesses and thought leaders. Harvey is
the Founder and Board President of the People of Color Psychedelic Collective,
long-time advocate for promoting drug policies grounded in science, compassion,
and human rights, as well as the Social Media Manager for Caring Across
Generations, an organization which creates a new way to live well and age with
dignity in America.
Harvey states, "I am excited to
push the boundaries of how we talk and think about wellness in our society at
Meet Delic. I want our society to truly value and create wellness for
everyone."
During her tenure at The Drug Policy
Alliance, which is the nation's leading organization advocating to end the war
on drugs, Harvey fought hard for people to no longer be punished for what they
put in their bodies. This created a deep desire within Harvey to further
champion that individuals be given the
sovereign right and choice to use alternative medicines such as psychedelics
without fear and impunity.
The experiential event will feature
dancers, music, 3D mapping, new technologies and research, thought-provoking
presentations and the world's largest psychedelic business expo.
"It is an honor to have Itefayo
Harvey speak at our conference and bring her unique perspectives on health,
life and culture to our attendees," said Delic co-founder, Jackee Stang.
"She is a powerful voice in the movement toward embracing psychedelic
wellness and reform and her work to right many wrongs in the 'war on drugs' is
remarkable."
The twenty hours of panels and
keynotes will include a broad array of topics such as: "How Psychedelics
Can be Effectively Used for Physical Optimization," "PTSD Reset and
Recovery," "Ketamine Clinics Today, Psilocybin and MDMA Therapy
Tomorrow," microdosing, activism, sexuality, and "Drug Use for
Grown-Ups." Musical and entertainment acts are scheduled both evenings
following the panels and expo.
Tickets are now available for the
two-day experience. For more information please visit, www.meetdelic.com.
Follow us on @meetdelic on Instagram, Twitter
and Facebook. Tickets
available now.
KetamineOne Capital
Limited
(NEO: MEDI) (OTC: KONEF), a company focused on
consolidating medical clinics and becoming a North American leader in mental
health treatments, announced that it has signed an exclusive
agreement for the use of virtual reality (“VR”) technology in psychedelic
treatments with OVR Tech LLC (“OVR Technology”) to provide its INHALE Wellness
Platform over an initial term of two years in Ketamine One’s clinics. The
INHALE Wellness Platform is an olfactory-enabled VR platform designed to deepen
immersion, promote relaxation and help manage stress.
Pursuant
to the terms and conditions of the exclusive agreement, OVR Technology will
provide its proprietary technology and services for Ketamine One to use with
its psychedelic-assisted treatments involving ketamine, psilocybin, DMT and
MDMA in order to help improve patient outcomes. OVR Technology’s INHALE
Wellness Platform combines the benefits of mindfulness, breathwork and
meditation with the next generation of aromatherapy. It includes a head-mounted
display, the ION device (the “ION”) and scent cartridges, as well as several
scent-focused nature scenes. The ION is lightweight, wireless and emits scent
particles in coordination with VR technology designed to deepen a patient’s
immersive experience.
OVR
Technology’s Architecture of Scent® platform brings together software,
Scentware™, and hardware via the ION, while also including replaceable
cartridges and an Olfactory Experience Engine that allows scent to be triggered
during a VR experience. Scents delivered through the ION are water-based and
made from a combination of natural and synthetic ingredients that have
undergone extensive testing. While VR technology is widely known to incorporate
sight and sound, this partnership provides Ketamine One with the capability to
generate more realistic Immersive Virtual Reality (“IVR”) service offerings via
scent at its network of clinics, which is expected to enhance experiences and
help improve patient treatment outcomes.
The
concept for the Architecture of Scent® and ION device was based on the idea
that scent in VR could dramatically increase immersion. Computer simulations in
which patients can interact within virtual three-dimensional environments can
help put patients in calming settings and improve relaxation through the
addition of scents. Research has shown that scents elicit emotional and
evocative associations and can immediately alter mood.1 Other research shows
that, as soon as an odor is registered by the brain, it activates the
amygdala-hippocampal complex in the limbic system where emotions, memories, and
associations are processed, nearly instantaneously.2
“We
believe that the ION device contains the most accurate on-mask scent technology
currently available on the market. The ability for our clinicians to alter
perceptual experiences with VR and the ION is extremely promising. Optimizing
the therapeutic setting is one of the main goals of our VR-based research and
development program and being able to utilize the sense of smell to help patients
relax, reduce tension and lower stress is expected to result in the development
of a comprehensive treatment,” said Dr. Quang Henderson, Chair of Ketamine
One’s Clinic Innovation Council.
“Our
access to a large patient population and enhanced research capabilities through
our wholly-owned contract research organization, KGK Science, along with OVR
Technology’s innovative platform, on a combined basis have the potential to
lead to clinically validated solutions for use not only in our facilities, but
also in patients’ homes, through the development of a portable digital
therapeutic offering in the future,” added Adam Deffett, Interim CEO of
Ketamine One.
“This
is the first VR platform that understands user behavior in the virtual world
and responds with real-time sensory stimulation. It has the potential to
significantly enhance the wellness capabilities of an already promising
technology,” said Aaron Wisniewski, CEO and co-founder of OVR Technology.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Learn
more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear
more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto
Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast
, Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye
Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for iPhone and Android
Join our
Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665
0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
